Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: Modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response

Dermatology

Volumn 223, Issue 1, 2011, Pages 57-67

  Quaglino, P ^a   Bergallo, M ^a   Ponti, R ^a   Barberio, E ^a   Cicchelli, S ^a   Buffa, E ^a   Comessatti, A ^a   Costa, C ^a   Terlizzi, M E ^a   Astegiano, S ^a   Novelli, M ^a   Cavallo, R ^a   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cytokines; Etanercept; Gene expression; Psoriasis; Regulatory T cells; Transcription factors

Indexed keywords

ETANERCEPT; GAMMA INTERFERON; INTERLEUKIN 12P35; INTERLEUKIN 2; INTERLEUKIN 23P19; INTERLEUKIN 4; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT3 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4+ CD25+ T LYMPHOCYTE; CELL POLARITY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT RESPONSE; UPREGULATION;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 80053965211     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000330330     Document Type: Article

References (39)

1. Yawalkar N, Karlen S, Hunger R, Brand CU, Braathen LR: Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 1998; 111: 1053-1057. (Pubitemid 29115174)
2. Nickoloff BJ: Cracking the cytokine code in psoriasis. Nat Med 2007; 13: 242-244. (Pubitemid 46376653)
3. Guttman-Yassky E, Nograles KE, Krueger JG: Contrasting pathogenesis of atopic dermatitis and psoriasis. Immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011; 127: 1420-1432.
4. Zhu K, Ye J, Wu M, Cheng H: Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris. Arch Dermatol Res 2010; 302: 517-523.
5. Wraith DC, Nicolson KS, Whitley NT: Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol 2004; 16: 695-701. (Pubitemid 39423656)
6. Buckner JH: Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010; 10: 849-859.
7. Quaglino P, Ortoncelli M, Comessatti A, Ponti R, Novelli M, Bergallo M, Costa C, Cicchelli S, Savoia P, Bernengo MG: Circulating CD4+CD25 bright FOXP3+ T cells are upregulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 2009; 219: 250-258.
8. Bak RO, Mikkelsen JG: Regulation of cytokines by small RNAs during skin inflammation. J Biomed Sci 2010; 17: 53.
9. Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S, Fortugno P, Gonzalvo-Feo S, Franssen JD, Parmentier M, De Pità O, Girolomoni G, Sozzani S: Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 2009; 206: 249-258.
10. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132. (Pubitemid 41541790)
11. Harrington LE, Mangan PR, Weaver CT: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18: 349-356.
12. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R: Development cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950-957. (Pubitemid 47300009)
13. Korn T, Bettelli E, Oukka M, Kuchroo VK: IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517.
14. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR: TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγt function. Nature 2008; 453: 236-240. (Pubitemid 351667978)
15. Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suárez-Fariñas M, Cardinale I, Khatcherian A, Gonzalez J, Pierson KC, White TR, Pensabene C, Coats I, Novitskaya I, Lowes MA, Krueger JG: Th17 cytokines, interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 2008; 159: 1092-1102.
16. Zhang N, Pan HF, Ye DQ: Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem 2011; 353: 41-46.
17. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG: Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-1211. (Pubitemid 351543220)
18. Rentenaar RJ, Heydendael VM, van Diepen FN, de Rie MA, ten Berge IJ: Systemic treatment with either cyclosporin A or methotrexate does not influence the T helper 1/T helper 2 balance in psoriatic patients. J Clin Immunol 2004; 24: 361-369. (Pubitemid 39005568)
19. Caproni M, Antiga E, Melani L, Volpi W, Del Bianco E, Fabbri P: Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol 2009; 29: 210-214.
20. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, Fuen-tes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA, Krueger JG: Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007; 204: 3183-3194.
21. Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG: Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 2009; 124: 1022-1110.
22. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A: Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2009; 130: 1373-1383.
23. Bosè F, Raeli L, Garutti C, Frigerio E, Cozzi A, Crimi M, Caprioli F, Scavelli R, Altomare G, Geginat J, Abrignani S, Reali E: Dual role of anti-TNF therapy: Enhancement of TCRmediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Clin Immunol 2011; 139: 164-176.
24. Zhu J, Paul WE: CD4 T cells: fates, functions, and faults. Blood 2008; 112: 1557-1569.
25. Zhu J, Paul WE: Peripheral CD4 T cell differentiation regulated by networks of cytokines and transcriptors factors. Immunol Rev 2010; 238: 247-262.
26. Annunziato F, Romagni S: Heterogeneity of human effector CD4+ T cells. Arthritis Res Ther 2009; 11: 257.
27. Ho IC, Tai TS, Pai SY: GATA3 and T-cell lineage: essential functions before and after Thelper-2-cell differentiation. Nat Rev Immunol 2009; 9: 125-135.
28. Wang L, Wildt KF, Zhu J, Zhang X, Feigenbaum L, Tessarollo L, Paul WE, Fowlkes BJ, Bosselut R: Distinct function for the transcription factor GATA-3 and ThPOK during intrathymic differentiation of CD4+ T cells. Nat Immunol 2008; 9: 1122-1130.
29. Gottlieb AB, Lebwohl M, Shirin S, Sherr A, Gilleaudeau P, Singer G, Solodkina G, Grossman R, Gisoldi E, Phillips S, Neisler HM, Krueger JG: Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study. J Am Acad Dermatol 2000; 43: 595-604.
30. Sterry W, Ortonne JP, Kirkham B, Brocq O, Robertson D, Pedersen RD, Estojak J, Molta CT, Freundlich B: Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentric trial. BMJ 2010; 340:c147.
31. Ozer A, Murat Aral SS, Pinar C: Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005: 5:273-279.
32. Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, Riente L, Ferrannini E: High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthritis. Clin Exp Rheumatol 2009; 27: 22-27.
33. Grewe M, Bruijnzeel-Koomen CA, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-361. (Pubitemid 28392277)
34. Elbe-Bürger A, Egyed A, Olt S, Klubal R, Mann U, Rappersberger K, Rot A, Stingl G: Overexpression of IL-4 alters the homeostasis in the skin. J Invest Dermatol 2002; 118: 767-778. (Pubitemid 34526538)
35. Guenova E, Volz T, Sauer K, Kaesler S, Müller MR, Wölbing F, Chen K, Schwärzler C, Brossart P, Röcken M, Biedermann T: IL-4-mediated fine tuning of IL-12p70 production by human DC. Eur J Immunol 2008; 38: 3138-3149.
36. Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlöndorff D, Plewig G, Sander CA, Röcken M: Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9: 40-46. (Pubitemid 36098258)
37. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-793. (Pubitemid 26372655)
38. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 1994; 76: 241-251. (Pubitemid 24046687)
39. Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, Seegmüller I, Voigt H, Launois P, Levine AD, Wagner H, Heeg K, Louis JA, Röcken M: IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2001; 2: 1054-1060. (Pubitemid 33069501)